Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Galapagos NV (GXE.BE)

23.04
0.00
(0.00%)
As of April 24 at 7:33:06 PM GMT+2. Market Open.
Advanced Chart
Loading Chart for GXE.BE
  • Previous Close 23.04
  • Open 0.00
  • Bid 22.72 x --
  • Ask 23.60 x --
  • Day's Range 23.04 - 23.04
  • 52 Week Range 20.36 - 31.02
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jul 23, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: GXE.BE

View More
View More

Performance Overview: GXE.BE

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is AEX-Index (^AEX) .

YTD Return

GXE.BE
12.26%
AEX-Index (^AEX)
0.76%

1-Year Return

GXE.BE
13.90%
AEX-Index (^AEX)
0.23%

3-Year Return

GXE.BE
60.56%
AEX-Index (^AEX)
21.57%

5-Year Return

GXE.BE
88.20%
AEX-Index (^AEX)
72.69%

Compare To: GXE.BE

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

GXE.BE
Galapagos NV
23.04
0.00%
Mkt Cap EUR -
Industry Biotechnology
BVXP.L
Bioventix PLC
2,500.00
0.00%
Mkt Cap GBp 130.622M
Industry Biotechnology
GMAB.CO
Genmab A/S
1,340.00
+0.75%
Mkt Cap DKK 83.498B
Industry Biotechnology
CPRX
Catalyst Pharmaceuticals, Inc.
23.19
+0.30%
Mkt Cap 2.828B
Industry Biotechnology
REGN
Regeneron Pharmaceuticals, Inc.
599.76
+2.03%
Mkt Cap 65.569B
Industry Biotechnology
BNTX
BioNTech SE
120.54
+4.97%
Mkt Cap 28.977B
Industry Biotechnology
VRTX
Vertex Pharmaceuticals Incorporated
492.47
+0.01%
Mkt Cap 126.605B
Industry Biotechnology

Statistics: GXE.BE

View More

Valuation Measures

Annual
As of 4/23/2025

  • Market Cap

    1.48B

  • Enterprise Value

    -1.63B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.36

  • Price/Book (mrq)

    0.51

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: GXE.BE

View More
View More

Company Insights: GXE.BE

Research Reports: GXE.BE

View More
View More

People Also Watch

ARGX.BR argenx SE
531.60
+0.76%
 
BAR.BR Barco NV
11.97
+3.82%
 
KIN.BR Kinepolis Group NV
31.90
+0.95%
 
ONTEX.BR Ontex Group NV
8.08
+0.75%
 
COLR.BR Colruyt Group N.V.
42.76
+0.23%
 
UCB.BR UCB SA
147.35
+0.41%
 
AGS.BR ageas SA/NV
53.75
+0.37%
 
DIE.BR D'Ieteren Group SA
168.50
-0.47%
 
BPOST.BR bpost NV/SA
1.4700
-0.41%
 
KBC.BR KBC Group NV
81.18
-0.61%
 
PROX.BR Proximus PLC
6.58
-0.68%
 
SOF.BR Sofina Société Anonyme
242.20
-0.08%
 
ACKB.BR Ackermans & Van Haaren NV
209.60
+1.35%
 
SOLB.BR Solvay SA
32.58
+1.24%
 
GREEN.BR Greenyard NV
7.00
0.00%
 
GBLB.BR Groupe Bruxelles Lambert SA
71.00
+0.57%